Ọgwụ "Vikasol": okwu

Nkwadebe "Vikasol" (mbadamba), ntụziaka ezipụta nwere 15 mg nke menadione sodium bisulfite.

Medicine "Vikasol" n'ụdị nke a ngwọta maka intramuscular injection bụla ampoule nwere 10 mg nke menadione sodium bisulfite.

The ọgwụ bụ nke na-adakarị na ọgwụ otu hemostatic mmadụ. Pharmaceutical edinam dabeere na eziokwu ahụ bụ na ọgwụ ọjọọ, "Vikasol" na-synthetically ịmepụta otu analogue nke vitamin K, soluble n'ime mmiri. Ọ na-egbochi guzobe prothrombin. Mmetụta bara uru na bekee aka na ọbara coagulation, rụọ ọrụ na imeju; Ọ na-enyere weghachi ọbara clotting usoro.

Akparamagwa nke menadione ke idem hụrụ awa iri na abụọ mgbe ochichi. Ọgwụ "Vikasol" (mbadamba) n'ụzọ zuru okè etinye obi gị dum site idem. Na ọbara interacts na plasma-edozi, nke a bụ reversible. Ebusa ọgwụ ìgwè ke ahụ bụ imeju, splin, myocardium. Na ụfọdụ ogbo nke metabolism nke menadione sodium bisulphite kpụrụ vitamin K2.

vitamin K decomposition ngwaahịa na-anọchi anya bisulfate, phosphate digdyukuronid-2-methyl-1,4-naphthoquinone, ruo 70% nke residues ewepụtara mmamịrị.

Ọgwụ "Vikasol": ntuziaka maka ojiji. na-agba akaebe

The ọgwụ na-kenyere:

• na hemorrhagic syndrome, jikọtara gipoprotrombinemiey;
• na a erughi nke vitamin K (ọrịa n'ịnwụ ọgwụgwọ nke jaundice, ịba ọcha n'anya, imeju, ruo ogologo oge afọ ọsịsa);
• haemorrhagic ọrịa na nwa ọhụrụ;
• na ịrịba ọbara na ọnwụ dị ka a n'ihi nke ọjọọ, trauma ma ọ bụ ịwa ahụ;
• na-arọ eriri akpa nwa na-agba ọbara na ọrịa ụmụ nwanyị;
• menorrhagia;
• maka agba ọbara n'ihi ọgwụ na otu anticoagulants, dị ka a kpọmkwem na-eti ọkpọ;
• Pregnancy na III trimester nke afọ ime iji gbochie na-agba ọbara na nwa ọhụrụ;
• na nkwadebe maka ịwa ahụ, mgbe ịwa ahụ;
• maka agba ọbara mere site gastric ọnyá afọ ma ọ bụ duodenal ọnyá afọ;
• na ukwuu gemorroidalnom na epistaxis.

Ọgwụ "Vikasol": ntụziaka na ngwa. onunu ogwu

Doctor edepụta okenye onu dose menadione sodium bisulfite, si 15 mg 30 mg. V / m, na dose bụ 10 mg 15 mg.

Children n'okpuru otu afọ nke afọ, ndị dose na-kenyere 2-5mg ọgwụ.

Children n'okpuru afọ 2 afọ, a na-kenyere 6 mg.

Children si 4 afọ 3y.o. ndimek 8 mg.

Children si 5 afọ ka 9 afọ kenyere 10 mg.

Children noo 10 afọ afọ 14 inye 15 mg.

Ndị a doses "menadione" ndinọ 2-3 ugboro n'ụbọchị. Na oge nke ọgwụgwọ dọkịta na-esetịpụrụ n'otu n'otu.

Ekwela gafere kwa ụbọchị dose n'ihi na ndị okenye - 60 mg onu, 30 mg intramuscularly. Ọ gaghị ekwe omume ka a otu dose n'ihi na ndị okenye dị elu karịa 30 mg onu, 15 mg intramuscularly.

The kacha allowable kwa ụbọchị dose "Vikasol" ọgwụ maka ụmụ ọhụrụ bụ 4 mg.

Ọgwụ "Vikasol": ntuziaka maka ojiji. mmetụta

Na-adakarị ọnwụnwa ọ dịla obere nfụkasị Jeremaya na gosi akpụkpọ ọkụ ọkụ, pruritus, erythema, urticaria, bronchospasm.

Nsogbu na usoro ọbara clotting nwere ike ime hemolytic ọrịa nke mụrụ nwa ọhụrụ.

Ọgwụ "Vikasol": ntuziaka maka ojiji. contraindications

Ọ gaghị ekwe omume nye iwu a ọgwụ:

• na ihe elu ọbara clotting;
• mgbaàmà nke thromboembolism;
• hypersensitivity ka menadione sodium bisulfite.

Ime ndị inyom na ara nne ha, ndị ọgwụ ọjọọ, "Vikasol" inye egosi.

adọ aka ná ntị

Ọrịa ndị na-guzosie ike ọrịa metụtara na outflow nke bile, ọgwụ na-ndinọ parenterally. Na ọgwụgwọ nke ọrịa na-ata ahụhụ site na hemophilia na ọrịa Verlgofa, na nkà mmụta ọgwụ "Vikasol" adịghị enye ezi ihe.

Iji ọgwụ n'out oge na onu anticoagulants ebelata anticoagulant mmetụta.